INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 137 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $727,072 | -81.1% | 13,958 | -80.3% | 0.00% | -87.5% |
| Q1 2023 | $3,840,210 | +2.3% | 70,918 | -0.1% | 0.01% | -27.3% |
| Q4 2022 | $3,754,992 | -29.7% | 70,956 | -38.2% | 0.01% | -31.2% |
| Q3 2022 | $5,338,000 | +270.4% | 114,734 | +354.6% | 0.02% | +220.0% |
| Q2 2022 | $1,441,000 | -4.9% | 25,239 | +2.0% | 0.01% | 0.0% |
| Q1 2022 | $1,515,000 | -8.3% | 24,755 | -21.7% | 0.01% | -16.7% |
| Q4 2021 | $1,653,000 | +17.7% | 31,600 | -16.2% | 0.01% | +20.0% |
| Q3 2021 | $1,405,000 | -79.8% | 37,700 | -77.8% | 0.01% | -81.5% |
| Q2 2021 | $6,943,000 | +1850.3% | 170,100 | +1520.0% | 0.03% | +1250.0% |
| Q1 2021 | $356,000 | -68.9% | 10,500 | -70.8% | 0.00% | -60.0% |
| Q4 2020 | $1,143,000 | -30.9% | 35,958 | -44.2% | 0.01% | -37.5% |
| Q3 2020 | $1,654,000 | +499.3% | 64,438 | +258.9% | 0.01% | +300.0% |
| Q1 2020 | $276,000 | -98.6% | 17,955 | -96.8% | 0.00% | -98.5% |
| Q4 2019 | $19,109,000 | +4677.2% | 556,960 | +941.0% | 0.13% | +4300.0% |
| Q3 2019 | $400,000 | -27.9% | 53,500 | +25.2% | 0.00% | -40.0% |
| Q2 2019 | $555,000 | -18.5% | 42,726 | -23.6% | 0.01% | 0.0% |
| Q1 2019 | $681,000 | +202.7% | 55,928 | +183.7% | 0.01% | +400.0% |
| Q4 2018 | $225,000 | +11150.0% | 19,711 | +9755.5% | 0.00% | – |
| Q2 2017 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 424,500 | $13,499,000 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $6,360,000 | 3.70% |
| Asymmetry Capital Management, L.P. | 130,654 | $4,155,000 | 1.90% |
| Altium Capital Management LP | 153,348 | $4,876,000 | 1.82% |
| Sofinnova Investments, Inc. | 848,162 | $26,972,000 | 1.61% |
| Bellevue Group AG | 3,659,919 | $116,386,000 | 1.33% |
| Eversept Partners, LP | 356,235 | $11,328,273 | 1.33% |
| Rhenman & Partners Asset Management AB | 500,000 | $15,900,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 347,497 | $11,050,000 | 1.09% |
| WASATCH ADVISORS LP | 6,333,900 | $201,418,000 | 0.99% |